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Abstract  
We set out to study whether single-subject grey matter (GM) networks show disturbances that 
are specific for Alzheimer’s disease (AD) (n=90) or behavioral variant Frontotemporal 
dementia (bvFTD) (n=59), and whether such disturbances would be related to cognitive 
deficits measured with Mini-mental state examination (MMSE) and a neuropsychological 
battery, using subjective cognitive decline subjects (SCD) as reference. AD and bvFTD 
patients had a lower degree, connectivity density, clustering, path length, betweenness 
centrality and small world values compared to SCD. AD patients had a lower connectivity 
density than bvFTD patients (F = 5.79, p = 0.02; Mean±SD bvFTD 16.10% ± 1.19; Mean±SD 
AD 15.64% ± 1.02). Lasso logistic regression showed that connectivity differences between 
bvFTD and AD were specific to 23 anatomical areas, in terms of local GM volume, degree 
and clustering. Lower clustering values and lower degree values were specifically associated 
with worse MMSE scores and lower performance on the neuropsychological tests. GM 
showed disease-specific alterations, when comparing bvFTD with AD patients, and these 
alterations were associated with cognitive deficits.  
Keywords: Alzheimer’s disease, behavioral variant Frontotemporal dementia, single-subject 
grey matter networks, structural networks, cognition. 
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1. Introduction 
Neurodegenerative disorders can cause a wide spectrum of clinicopathological presentations. 
The most common early-onset dementia is Alzheimer’s disease (AD), followed by behavioral 
variant Frontotemporal dementia (bvFTD)(Ikeda et al., 2004; Rosso, 2003). AD is 
histopathologically defined by the presence of amyloid-beta plaques and tau-related 
neurofibrillary tangles in the brain (H. Braak and E. Braak, 1991; McKhann et al., 2011). 
Impaired memory is the most common clinical sign of the illness, but patients can suffer from 
other symptoms as well. Specifically, early-onset AD patients can present with impaired 
functioning in domains other than memory, such as decline in visuospatial and executive 
functioning (Murray et al., 2011; Smits et al., 2014). BvFTD has a more heterogeneous 
histopathological definition, which can be the presence of tau-protein, transactive response 
DNA binding protein 43 or fused in sarcoma protein in the brain (Mackenzie et al., 2009; 
Rascovsky et al., 2011). The most common clinical signs of bvFTD are changes in the 
regulation of social, interpersonal and personal conduct with predominant executive 
dysfunction. Memory impairment is occasionally also found in bvFTD patients as an initial 
feature (Graham, 2005; Hodges et al., 2004). 
 
Both AD and bvFTD show a disease-specific anatomical pattern of cortical atrophy. In bvFTD 
patients atrophy is commonly seen in the anterior cingulate cortex, insular cortex, 
dorsomedial prefrontal cortex, striatum and thalamus (Boccardi et al., 2005; Krueger et al., 
2010; Seeley et al., 2009). In AD patients, atrophy is commonly observed in the medial 
temporal cortex, precuneus, posterior cingulate cortex, parietal and occipital cortex (Buckner 
et al., 2005; Seeley et al., 2009). Although these disorders have their own atrophy patterns, 
bvFTD can shown medial temporal or parietal atrophy (Pievani et al., 2014; Rohrer et al., 
2010), and AD prominent frontal atrophy (Johnson et al., 1999; Ossenkoppele et al., 2015). 
So, it is difficult to attribute the wide spectrum of clinical symptoms in AD versus bvFTD 
(Varma et al., 1999) to site of atrophy alone. Possibly, this is due to the fact that the brain is a 
complex network, in which localized volumetric changes can have unpredictable effects on 
brain functioning (Gratton et al., 2012). As such, a network description or connectivity of the 
brain is likely to better explain differences in clinical expression across neurodegenerative 
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disorders. In addition, connectivity of the brain can be studied by structural or functional 
analyses. The difference between structural and functional networks is that structural 
connectivity conveys information of the spatial organization of anatomical regions and their 
connecting pathways using modern non-invasive imaging technics and functional connectivity 
conveys information about the temporal organization between those anatomical regions using 
e.g., resting-state fMRI. 
 
 One of the ways to study structural brain connectivity is to measure structural co-variance 
network (SCN) of grey matter as measured with structural MRI. This method provides a 
precise quantitative description of cortical structure by representing brain morphology as a 
network in which each cortical area represents a node and nodes are connected by edges 
when they show as statistical covariance in their morphometric features (local thickness and 
folding structure of the cortex). Patterns of coordinated grey matter morphology have been 
proposed to reflect functional co-activation (Alexander-Bloch et al., 2013; Andrews et al., 
1997; Bailey et al., 2014; Hopkins, 2004; Krongold et al., 2015), axonal connectivity (Budday 
et al., 2014; Gong et al., 2012) and/or genetic factors (Chen et al., 2013; Schmitt et al., 2009; 
2008). Analogously, brain areas that are involved in specific cognitive or behavioral functions 
seem to deteriorate in a coordinated way (Sepulcre et al., 2012; Voss and Zatorre, 2015). 
Grey matter connectivity is disrupted in Alzheimer’s disease, and is associated with disease 
severity(Tijms et al., 2014). An advantage of describing brain structure as a network is that 
networks can be precisely described using tools from graph theory. Such tools describe how 
information can be efficiently processed, and many network in nature show a balance 
between information integration (as indicated by short path lengths) and segregation of 
specialized clusters of nodes (as indicated by high clustering coefficient values). A few 
studies have compared grey matter networks between bvFTD and AD patients (Hafkemeijer 
et al., 2016; Seeley et al., 2009) and have illustrated that these disorders show anatomically 
distinct grey matter networks, which suggests that bvFTD pathology targets different networks 
than Alzheimer’s disease pathology. In line with these findings, studies using a functional 
network approach suggest that brain networks might alter in a disease specific way: In AD, a 
more ‘random’ network and less activity in default mode network (DMN) has been described, 
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while bvFTD has a more ‘ordered’ network and less activity in the Salience network (SN)(de 
Haan et al., 2009; Filippi et al., 2013; Hafkemeijer et al., 2015; Stam et al., 2007; Zhou and 
Seeley, 2015). Such ‘random’ networks show lower values of clustering and path length, 
while ‘ordered’ networks show higher values for those properties. Both effects however reflect 
a deviation from an optimal network configuration in which integration and segregation of 
information is balanced. Thus, bvFTD and AD show differences in the organization of 
structural networks, but it is still unclear as to how such connectivity measures of grey matter 
differ between bvFTD and AD at a single subject level and whether such alterations are 
associated with inter-individual differences in cognitive impairment. 
 
Also, most of these structural brain network studies restricted their investigations to the 
architecture of the networks in different types dementia and did not assess if these disease-
specific networks are related to the clinical symptoms. Although one study investigated SCN 
in bvFTD and described no correlating between network properties and the frontal 
assessment battery (FAB) score(Hafkemeijer et al., 2016). A possible explanation of that 
finding is because that study investigated one specific network, potential associations with 
FAB scores outside that network will not be picked up. Potentially, a whole brain approach 
provides an alternative way to investigate this question.  
 
Therefore, this paper attempts to show that global and/or local structural network properties 
measured with single-subject grey matter graphs differ between bvFTD and AD. Furthermore, 
we will investigate if these altered network properties correlate with clinical dysfunction. 
Based on the literature described above, we expected that in AD structural network properties 
would show a more random topology in comparison to grey matter networks of bvFTD 
patients, who we expected to show a more ordered topology. In addition, we studied whether 
disease-specific disrupted network properties were associated with impaired cognitive 
functioning as measured with Mini-mental state examination (MMSE) and with an extensive 
neuropsychological testing battery, including assessments in the domains of memory, 
language, visuospatial, attention and executive functions. For comparison, we also evaluated 
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differences between networks of AD and bvFTD patients with those of subjects with 
subjective cognitive decline (SCD) as a reference group. 
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2. Methods 
 
2.1 Subjects 
In this study we selected from the Amsterdam Dementia Cohort(van der Flier et al., 2014) 59 
consecutive patients with probable bvFTD (n= 54) or definite bvFTD (n= 5 histopathological-
confirmed cases) and 90 age, gender and MRI-scanner matched patients with probable AD 
who had a positive cerebrospinal fluid (CSF) AD biomarker profile (Duits et al., 2014; 
McKhann et al., 2011) and 74 subjects with SCD and normal CSF biomarkers. All subjects 
underwent a standardized diagnostic work up, which included a medical and neurological 
investigation including a medical history, a cognitive examination by a neurologist (including 
the mini-mental state examination (MMSE), Folstein et al., 1975), an informant-based history, 
neuropsychological investigation, magnetic resonance imaging (MRI) of the brain, 
electroencephalogram (EEG) and standard lab work. In most patient’s cerebrospinal fluid 
(CSF) was obtained. A clinical diagnosis of probable or definite bvFTD or probable AD was 
established during a multidisciplinary consensus meeting based on international clinical 
consensus criteria (McKhann et al., 2011; Rascovsky et al., 2011). The local institutional 
ethical review board approved this study and a written informed consent was obtained from 
all participants. 
 
2.2 Neuropsychological assessment 
Global cognitive performance was assessed with the MMSE(Folstein et al., 1975). The 
neuropsychological test battery was designed to screen for five major cognitive domains; 
memory, language, visuospatial, attention and executive function. The following tests were 
selected: The forward condition of Digit Span Test from the Wechsler Adult Intelligence 
Scale-III (WAIS-III) (Wechsler, 1981) and Trail Making Test part A (TMT A) (Reitan, 1958) 
were used to asses the domain attention. For memory, the total immediate recall score of the 
Rey Auditory Verbal Learning Task (RAVT) for 15 words(Rey, 1964) and the Visual 
association test(Lindeboom et al., 2002) was used. The Animal Naming fluency (Category 
Fluency) (Luteijn and van der Ploeg, 1983) and Letter Naming fluency (Letter D,A and 
T)(Benton and Hamsher, 1976) was used to assess the verbal ability and language skills. 
Furthermore, executive function was assessed by the Trail Making Test part B (TMT B) 
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(Reitan, 1958) and backward condition of Digit Span Test from the Wechsler Adult 
Intelligence Scale-III (WAIS-III) (Wechsler, 1981). For the visuospatial domain, three subtests 
of the visual object and space perception battery (VOSP) were used; incomplete letters, dot 
counting and number location (Warrington and James, 1991). In our study, 42.2% of the 
subjects completed all of the neuropsychological tests. Some tests were not finished either 
due to the severity of cognitive deficits or due lack of time. In order to avoid bias, we used 
multiple imputation as implemented in SPSS version 22.0 to estimate missing values. Age, 
gender, MMSE and global graph properties were used as additional predictor variables in 
order to reduce the estimation bias. Imputation of the data was repeated for 50 times. For 
each imputed dataset, the neuropsychological data was Z-transformed. TMT A and TMT B 
were inverted by computing -1*score, because higher scores imply worse performance. The 
z-scores were then averaged to provide a single composite score for each of the five 
domains.  
 
2.3 CSF analyses 
Lumbar puncture was performed according to a standard medical procedure in the lateral 
position (L3-L4, L4-L5 or L5-S1 intervertebral space) by a 25-gauge needle and syringe. CSF 
was collected in polypropylene tubes and centrifuged within an hour. The supernatant was 
stored in 0.5 ml aliquots at -20 ºC. Laboratory analysis CSF biomarker levels took place at the 
department of Clinical Chemistry of the VUmc as previously reported(Mulder et al., 2010). 
Total-tau (CSF tau), phosphorylated-Tau (CSF p-tau181) and levels of CSF Amyloid-β1-42 
(CSF Aβ1-42) concentrations were determined with sandwich ELISAs (Fujirebio/Innogenetics, 
Belgium). AD CSF profile was defined according to previously published cut-off values; <550 
pg/ml for CSF Aβ1-42, >375 pg/ml for CSF tau, and >52 pg/ml CSF p-tau181(Duits et al., 2014) or 
isolated reduced <550 pg/ml for CSF Aβ1-42. 
 
2.4 Image acquisition and pre-processing  
MR scans were acquired across 5 different scanners using an established standardized MRI 
protocol(van der Flier et al., 2014) including a 3D T1-weigthed gradient-echo sequences. 
Patients were selected and matched on scanner type, and so scanner types were equally 
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distributed between the three groups (see supplementary table S1). Scans were reviewed by 
experienced neuroradiologists for brain pathologies other than atrophy. The structural T1 
weighted images were segmented into cerebrospinal fluid, white and grey matter by using the 
Statistical Parametric Mapping software (SPM12; Functional Imaging Laboratory, University 
College London, London, UK) implemented in MATLAB 7.12 (MathWorks, Natick, MA). The 
quality of the segmentation was visually rated (YJH), and no scans had to be excluded. Next, 
for each grey matter segmentation-map, 90 anatomical regions were identified with the use of 
the standardized anatomical labelling from the Automated Anatomical Labelling atlas 
(AAL)(Tzourio-Mazoyer et al., 2002) using the inverted parameters that were calculated when 
normalizing subject space images to standard space. 
 
2.5 Single subject grey matter networks and graph properties 
Single subject grey matter graphs were based on intra-cortical similarity using an automated, 
data-driven method as previously described(Tijms et al., 2012). We assessed the following 
network properties of the average of all the nodes (global properties): the size of the network 
(i.e., the set of all nodes in the network), connectivity density (i.e., the percentage of existing 
connections to the maximum number of possible connections), average degree (i.e., number 
of links connected to a node), average path length (i.e., the shortest distance between two 
nodes), average clustering coefficient (i.e., the number of existing connections between 
nearby nodes to the maximum possible amount of connections), average betweenness 
centrality (i.e., the ratio of all shortest paths that pass through a node). Furthermore, we 
measured the small world network property, which is defined as having more clustering than 
a random network and with the average path length similar to that of a random network 
(Watts and Strogatz, 1998). The average normalized clustering coefficient and path length of 
each network was measured with the averaged from 20 randomized reference network of 
identical size and degree distribution(Maslov and Sneppen, 2002). Normalized clustering 
coefficient was indicated as gamma (γ), and normalized path length was indicated as Lambda 
(λ). In order to reduce dimensionality of the data and to aid interpretation in the context of 
previous network literature, we averaged for each anatomical AAL area the network 
properties across the nodes that fell within that region.  
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2.6 Statistical analysis  
Data analysis was performed using R version 3.2.3. The clinical and demographics baseline 
characteristics were compared for continuous data using one-way ANOVA and categorical 
data using chi-square test. Comparisons between AD, bvFTD and SCD of the global graph 
properties were tested with ANCOVA using total grey matter volume, age, gender and 
scanner as covariates. The assumption of normality of distributions for network properties 
was visually inspected with plots and histograms; if not met log-transformation was used 
(connectivity density). For all network properties the assumption of homogeneity of variance 
between the groups was met as verified with Levene’s test (all p>0.05). Lasso logistic 
regression analysis was used to select out of all the volumetric and network variables, the set 
of regional volumetric and network properties (predictors) that resulted in the best 
differentiation between AD/bvFTD versus SCD and AD versus bvFTD (dependent variables), 
while correcting at the same time for multiple hypothesis. All analyses were adjusted for the 
influences of age, gender and scanner type. The pseudo R2 of the resulting model was 
determined with McFadden’s ρ2.  Associations between the disease-specific network 
properties and MMSE scores and test-scores (z-scores) of the five domains were determined 
with Spearman’s correlations (rho), stratified for AD and bvFTD subjects. 
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3. Results 
3.1 Clinical and demographic characteristics 
Clinical and demographical characteristics of the subjects are shown in table 1. Groups 
showed similar distributions of gender, age and disease duration. Clinical Dementia Rating 
scale (CDR) was significantly different for AD and bvFTD patients compared to the SCD 
group. AD patients had lower MMSE scores than bvFTD patients and SCD subjects 
(p<0.001). Global grey matter volume was significantly higher in the SCD group compared to 
AD and bvFTD. Table 2 summarizes the outcome of the subjects’ neuropsychological 
assessment battery and shows that AD and bvFTD patients have significantly worse 
performance on all the cognitive tests compared with SCD. More specific, AD patients had 
the lowest tests results in all cognitive tasks compared to bvFTD, apart from the letter fluency 
which showed the lowest scores in the bvFTD group.  
 
3.2 Grey matter network properties in AD and bvFTD versus SCD subjects 
Figure 1 shows that in comparison to controls, networks of AD and bvFTD patients had lower 
degree values (F(2,212)=17.50 , p <.001) and lower connectivity density values 
(F(2,212)=13.28, p <.001). After additionally correcting for connectivity density, networks of 
AD and bvFTD patients still showed lower values of the clustering coefficient 
(F(2,212)=13.28, p <.001), path length (F(2,212)=17.21, p <.001), betweenness centrality 
(F(2,212)=13.92, p <.001), lambda (F(2,212)=17.35, p <.001), gamma (F(2,212)=20.14, p 
<.001) and lower small world properties (F(2,212)=17.50, p <.001). 
 
Lasso logistic regression models comparing SCD versus AD subjects selected besides 
hippocampal atrophy also other locations of atrophy. In addition, network measures 
clustering, path length and betweenness centrality were selected (See supplementary table 
S2). A model including only the selected local atrophy measures explained 35% of the 
variance. Adding the selected grey matter network properties explained 73% of the variance, 
which was a significant improvement (p <.001). 
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Lasso logistic regression models comparing SCD versus bvFTD subjects selected atrophy of 
the caudate nucleus, hippocampal atrophy and atrophy of the gyrus rectus. In addition, local 
clustering and path length measures were selected (See supplementary table S3). A model 
including only the selected local atrophy measures explained 24% of the variance. Adding the 
selected grey matter network properties explained 41% of the variance, which was a 
significant improvement (p <.001). 
 
3.4 Grey matter network properties in bvFTD versus AD 
Grey matter networks of AD patients had a lower connectivity density than those of bvFTD 
patients (F(1,140) = 5.79, p = 0.02). As a result, networks of AD patients showed a lower 
global clustering coefficient value (F(1,140) = 3.79, p = 0.05). In addition, the small world was 
lower in AD, but after taking into account covariates, this difference was not significant (p=.50) 
(Figure 1). No further differences were found between the groups.  
 
Lasso logistic regression was used to determine the set of local volumetric and network 
properties that reliably differed between bvFTD and AD patients (figure 2). Local grey matter 
volume, degree and clustering of several frontal, temporal and also posterior cortical areas 
were selected (table 3). Networks of bvFTD patients show in comparison to those of AD 
patients a lower clustering value in the left angular gyrus and less grey matter volume in the 
left thalamus. Networks of AD patients show in comparison to those of bvFTD patients a 
lower degree value in left superior occipital, a lower clustering in the right paracentral cortex, 
and less grey matter volume in the left angular cortex. Together, these variables could 
distinguish between bvFTD and AD patients with a sensitivity of 92% and specificity of 95%. 
A simple model that included only local volumetric selected variables explained 46% of the 
variance between AD and bvFTD patients. This model improved significantly by included the 
lasso selected local grey matter properties (degree and clustering), which then explained 70% 
of the variance (p<.001). 
3.5 Grey matter network properties and cognitive impairment  
We further studied whether local network properties that differentiated between bvFTD and 
AD subjects were associated with impaired in cognition as measured with MMSE and the 
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neuropsychological assessment battery (table 4). For global cognition, lower scores on the 
MMSE were associated with more atrophy in 9 of the selected regions and with a lower 
degree in the right middle occipital gyrus in AD patients. The strongest correlations were in 
the left angular gyrus, right precuneus and insula. Lower MMSE scores were also associated 
with lower clustering coefficient value in the right hippocampus and more atrophy in the 
superior frontal region in bvFTD patients. Impaired memory and impaired visuospatial 
functioning was not associated with any grey matter network property or volume. Worse 
language abilities were associated with the left hippocampus in bvFTD patients. Impaired in 
attention and executive functioning in AD patients showed significant associations with local 
atrophy and network measures in similar cortical areas, including atrophy in the left superior 
frontal gyrus, right superior frontal gyrus, right insula, and posterior areas. For network 
properties in AD, worse performance on these tests were associated with lower degrees in 
the left thalamus, the right middle temporal gyrus and occipital regions. For bvFTD, 
impairment in executive functioning was associated with atrophy in the superior frontal gyrus 
and lower clustering in the right hippocampus. A lower attention in bvFTD patients was 
associated with a lower degree in superior occipital gyrus. 
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4. Discussion 
We set out to show that global and/or local structural network properties measured with 
single-subject grey matter graphs differ between bvFTD and AD and found that these 
disorders have significant different global and local grey matter network properties compared 
to controls. Our main finding is that grey matter networks of AD patients showed lower 
connectivity density and global clustering values compared to bvFTD patients, which is 
suggestive of a less ordered, or more random network organization in AD. Furthermore, we 
found that disruptions of grey matter volume together with network properties degree and 
clustering coefficient values of specific anatomical areas differentiated these two 
neurodegenerative disorders. In addition, we were able to show that grey matter volume and 
grey matter network properties in specific anatomical areas were associated with cognitive 
disturbances measured with MMSE and the neuropsychological assessment battery covering 
5 different domains. Together, our results provide further support for the hypothesis that grey 
matter networks in neurodegenerative disorders are altered in a disease-specific way.  
 
We found clear differences between structural grey matter networks in AD and bvFTD on 
various local degree and clustering values in disease-specific anatomical regions. This is in 
line with previous observations in studies that describe differences in grey matter networks 
between these disorders. One study reported anatomically distinct grey matter networks on a 
group level for five different types of dementia(Seeley et al., 2009), including AD and bvFTD. 
In another study, grey matter networks on group level in bvFTD and AD targeted also 
different networks, where bvFTD was associated with anterior cingulate networks (SN) and 
AD with precuneal networks (DMN)(Hafkemeijer et al., 2016). Moreover, previous studies with 
single-subject grey matter graphs in AD patients showed a more ‘random’ network 
organization that correlated with the decline in cognition(Tijms et al., 2014; 2013). Here, we 
also found indications that in AD grey matter networks showed a more random connectivity 
organization in comparison to controls, and more random than networks organization in 
bvFTD. This difference was mostly driven by a decrease in connectivity density in AD. Since 
small world properties indicate a balance between local processing and global integration 
which is the basis for normal cognition, the finding of a more random network in AD might 
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explain that these patients clinically presented with more cognitive impairment than bvFTD 
patients. As previously argued for bvFTD, the pathologically ordered architecture in bvFTD 
patients could be due to the altered long-distance connections from the frontal regions with 
other brain regions(de Haan et al., 2009). It is then conceivable that this process contributes 
to clinical symptoms of abnormal behaviour and in a lesser extent cognitive deficits. 
 
At this point comparisons of brain connectivity alterations between AD and bvFTD as 
measured with a graph theoretical approach have only been studied based on functional 
connectivity. Using EEG, a previous study reported that in comparison to controls subjects, 
AD patients showed lower normalized clustering coefficient values (Stam et al., 2007), while 
bvFTD patients showed higher normalized clustering coefficient values which is suggestive of 
a more ‘ordered network’(de Haan et al., 2009). That study also showed a lower normalized 
path length values in both AD and bvFTD subjects in comparison to controls. Our results are 
in line with the normalized path length findings, but contrast the normalized clustering 
findings. Possibly, the divergence in results is caused by network construction methods, as 
we made sure that all networks included only connections that survived a statistical threshold, 
while the previous study enforced the same number of connections in all networks that might 
introduce differences in the level of noise included. Although the precise relationship between 
functional connectivity and grey matter networks is still unclear, there is supporting evidence 
that functional brain networks as determined with MRI show more overlap with grey matter 
networks(Seeley et al., 2009; Zhou and Seeley, 2015). Recently, one study showed disease-
specific structural white matter and grey matter alterations and hypoperfusion patterns for AD 
and bvFTD, and found that these structural properties were consistent with the hypoperfusion 
(Steketee et al., 2016). However, future studies should further investigate the relationship 
between spatial and temporal organizations of the connectivity changes in bvFTD and AD. 
In our study, alterations in grey matter network properties showed disease specific anatomical 
patterns between AD and bvFTD. Grey matter networks from bvFTD patients were 
associated with a lower clustering value in the left angular gyrus, which is in line with clinical 
observations described in bvFTD: For example, bvFTD patients show loss of the ability to 
combine conceptual information in language and thought, which is related with the 
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heteromodal association cortex of the angular gyrus(Price et al., 2015). However, lower 
clustering values in the angular gyrus did not correlate with impaired functioning in any of the 
cognitive domains. In addition to a lower clustering coefficient value, we found that bvFTD 
patients showed less grey matter volume in the left thalamus. Previous studies have reported 
similar alterations in bvFTD and reported that less grey matter volume of the thalamus might 
be associated with the loss of the ability of processing social and emotional information 
(Krueger et al., 2010; Rosen, 2005; Seeley et al., 2009). These results are in line with a 
previous structural covariance study that reported that the thalamus, a key area of the 
‘Salience’ network (SN), showed less activity in functional network studies among bvFTD 
subjects (Agosta et al., 2013; de Haan et al., 2009; Filippi et al., 2013; Hafkemeijer et al., 
2016; Zhou et al., 2010). Possibly, the loss of function of this area is associated with 
structural alterations in bvFTD supporting the hypothesis that clinical symptoms, functional 
and structural alterations are closely related. 
Grey matter networks of AD patients showed lower degrees in left superior occipital and lower 
clustering in the right paracentral lobule in comparison to grey matter networks of bvFTD 
patients. These areas overlap with those previously reported areas that are involved with the 
default mode network, a resting-state functional connectivity network that has been described 
to be disrupted in AD and that is related with the neuropathology for this illness (Buckner et 
al., 2005). Likewise, we found more atrophy in the left angular cortex in AD patients, an area 
also found in AD histopathology(H. Braak et al., 2006). In general, the findings that grey 
matter networks are changed in these areas raises the question whether these altered grey 
matter network properties also correlate with the neuropathology of neurodegenerative 
disorders and this should be further investigated in future research.  
 
We found several associations between altered local grey matter network properties and 
worse cognitive impairment as measured with the MMSE and the neuropsychological 
assessment battery specific for bvFTD or AD. In AD patients, our previous study showed that 
the MMSE correlates with lower average path length and lambda values(Tijms et al., 2013). 
Likewise, we here found that in AD patients a lower degree in the right middle occipital gyrus 
and lower grey matter volumes in 9 brain regions were specifically correlated with decline in 
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the general cognition measured with the MMSE. Only volume loss in the left superior frontal 
gyrus and lower clustering in the right hippocampus in bvFTD patients were correlated with 
the MMSE. We further found that lower clustering in the right hippocampus was associated 
with executive functions and the left hippocampus was associated with language in patients 
with bvFTD and not with memory in AD patients, which was unexpected. A possible 
explanation is that memory scores showed floor effects for AD patients which complicates 
assessing statistical relationships, while test scores for executive function showed more 
variability in scores.  
 
Moreover, a previous structural MRI connectivity study that used a group-level approach and 
determined network integrity by assessing the residuals of a patient with regard to the group 
mean also found an association with the MMSE and specific grey matter connectivity in AD. 
However, that study did not find any associations of the Frontal assessment battery (FAB) 
and grey matter connectivity in bvFTD (Hafkemeijer et al., 2016). We did not study the FAB 
because previous studies show that it does not differentiate bvFTD from AD(Castiglioni et al., 
2006). Instead we chose to study associations with impaired functioning in 5 cognitive 
domains. Overall, AD subjects showed the most impaired functioning in all domains, 
suggesting that these patients were more severe impaired. However, patients did not differ in 
CDR and disease duration. This complicates further assessment of disease specific 
symptoms. In general measuring symptoms in bvFTD is problematic since most cognitive 
tests were mostly developed to test for an AD-type of dementia, which might not accurately 
capture the behavioral symptoms of bvFTD patients. Our study shows that with regard to 
brain structure, a specific set of cortical areas can be associated distinctly with bvFTD, and 
this suggests that brain structural changes might better explain differences between these 
clinical syndromes. Still, more research is needed to improve measuring bvFTD specific 
cognitive and behavioral abnormalities. 
 
Specific cases of AD and bvFTD can show cortical atrophy in the same region presenting with 
different symptomology(Pleizier et al., 2012), which so hampers the correct clinical diagnosis 
based on atrophy. Our results show that grey network measurements contribute disease-
                                                                                                                   Vijverberg et al. 18 
specific knowledge on top of volumetric properties and that these network properties correlate 
with cognitive symptoms that are found in these neurodegenerative disorders. Based on our 
results, when using grey matter network properties, we might be able to distinguish better 
between controls and these disorders and so accomplish an early accurate diagnose and 
correct counselling and treatment of patients. Which leads to a reduced burden on their 
caregivers. In addition, for clinical trial development grey matter networks might serve as a 
tool to refine inclusion criteria, increasing potential effects. In order to extend and validate the 
disease specificity of network properties and bridging the explanatory gap between symptoms 
and disease, more investigations should be conducted that correlate network properties with 
more clinical signs such as neuropsychiatric symptoms and abnormalities found in a 
neurological examination.  
 
A potential limitation of our present study is that we included a few pathologically proven 
diagnoses, so we had to rely on the clinical consensus diagnosis. However, all AD patients 
had a CSF AD profile(Duits et al., 2014) and all included patients were extensively screened 
and diagnoses were established during a multidisciplinary consensus meeting based on 
international clinical consensus criteria. Furthermore, we included patients from the real-
life/clinical routine that is conducted in the Amsterdam Dementia Cohort. As a result, patients 
were scanned on different types of scanners, which might add noise in the data. However, it 
is unlikely that this has influenced our results as we matched patients based on MRI-scanner 
type and we have included this as a covariate to our analyses. Another limitation of high 
dimensional data is that of multiple testing and multicollinearity. We have used Lasso 
regression, which is a technique designed to deal with these issues and provides a way to 
extract a minimal set of predictors that can dissociate between groups of people. Overfitting 
of the data was avoided by cross-validation. Our results show that AD typical areas were 
chosen such as the hippocampus and left angular gyrus. Also, areas known to be involved in 
bvFTD such as left thalamus and several frontal areas were selected by this technique, 
supporting its validity. Still, less typical areas were also selected such as the occipital areas. 
Although less often reported to be characteristic in a uni-variate way, these areas have been 
reported previously to show network alterations in AD(Binnewijzend et al., 2013). This also 
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shows that local alterations in a complex network such as the brain can have widespread, 
unexpected effects and such effects can only be captured with tools that take into account 
brain connectivity. With the lasso regression we were able to identify a set of predictors had 
the best distinguishing value, and so specific uni-variate associations within this set should be 
interpreted only within this context. At the least, by employing an unbiased approach we were 
able to improve the distinction between bvFTD and AD, and the predictors we found should 
be further validated in independent data sets. 
 
5. Conclusions 
In summary, we found that single-subject grey matter network patterns differ between 
controls and neurodegenerative disorders. Furthermore, we found that adding network 
measured to atrophy estimated improved the distinction between AD and bvFTD, and these 
areas showed significantly associations with cognitive decline as measured with the MMSE 
and a neuropsychological assessment battery. This suggests that grey matter networks 
properties might have use for clinical practice by helping to distinguish between these 
neurodegenerative disorders. 
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Tables 
 
Table 1. Subjects characteristics. 
 
  
bvFTD AD SCD p-value* 
Pairwise 
comparisons 
Sample size 59 90 74 
  
Age, mean (SD) 62.1 (6.0) 63.1 (6.1) 61.3 (6.6) 0.22 HC, bvFTD, AD 
Gender (f/m) 23/36 36/54 25/49 0.70** HC, bvFTD, AD 
Disease duration (SD) 3.7 (3.7) 3.4 (2.3) 4.6 (6.4) 1.00 
HC, bvFTD, AD 
CDR (SD) 0.97 (0.6) 0.94 (0.4) 0.22 (0.29) <0.001 HC>bvFTD, AD 
MMSE, mean (SD) 24.6 (3.5) (n=58) 21.1 (5.0) (n=87) 28.3 (1.9)(n=73) <0.001 HC>bvFTD>AD 
Grey matter volume in 
cm3, mean (SD) 
576.6 (97.6) 559.8 (75.7) 628.3 (76.7) <0.001 HC>bvFTD, AD 
 
Keys: bvFTD, behavioral variant Frontotemporal dementia; AD, Alzheimer's disease; SCD, Subjective cognitive 
decline; CDR, Clinical dementia rating scale; MMSE, Mini Mental-State Examination. *Significant tested using one-
way ANOVA with post-hoc test bonferroni, unless otherwise stated. **: Chi-square test.  
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Table 2.  Pooled neuropsychological test performance of bvFTD, AD and SCD 
categorized in five cognitive domains. 
 
bvFTD (N=59) AD (N=90) SCD (N=74) p-value* 
Pairwise 
comparisons 
Memory      
   Visual Association Test 10.2 (2.9) 6.5 (4.3) 11.8 (0.8) <0.001 SCD>bvFTD>AD 
   RAVT 27.1 (8.8) 21.4 (8.5) 40.3 (8.6) <0.001 SCD>bvFTD>AD 
Language      
   Category Fluency 13.7 (6.1) 13.0 (5.4) 21.7 (6.1) <0.001 SCD>bvFTD>AD 
   Letter Fluency  21.6 (12.6) 26.8 (13.0) 34.0 (11.6) <0.001 SCD>AD>bvFTD 
Visuospatial      
   Incomplete Letters 17.4 (4.4) 13.4 (6.8) 19.8 (2.3) <0.001 SCD>bvFTD>AD 
   Dot Counting 9.4 (1.6) 8.3 (2.3) 9.7 (1.0) <0.001 SCD>bvFTD>AD 
   Number Location 8.7 (2.0) 7.3 (2.7) 9.2 (1.1) <0.001 SCD>bvFTD>AD 
Attention      
   Trail Making Test A 69 (58.9) 103.8 (78.2) 42.1 (21.8) <0.001 SCD>bvFTD>AD 
   Digit Span Forward 11.1 (3.2) 10.1 (3.1) 12.5 (3.3) <0.001 SCD>bvFTD>AD 
Executive      
   Trail Making Test B 217.4 (168.3) 332.8 (210.5) 98.6 (57.4) <0.001 SCD>bvFTD>AD 
   Digit Span Backward 7.0 (2.9) 5.7 (2.8) 8.9 (2.8) <0.001 SCD>bvFTD>AD 
 
Keys: bvFTD, behavioral variant Frontotemporal dementia; AD, Alzheimer's disease; SCD, Subjective cognitive 
decline; RAVT, Rey Auditory Verbal Learning Task. Missing data were replaced by the corresponding estimates from 
multiple imputation (average across 50 imputed datasets, standard deviation). *Significant tested using one-way 
ANOVA with post-hoc test bonferroni.  
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Table 3. Lasso logistic regression outcome of the local properties which were different 
between bvFTD versus AD (OR). 
 
Network 
property 
Cortical region OR (95% CI)  
Disease 
specific 
volume L superior frontal gyrus, orbital 5.75 (0.83-.55.8) AD>bvFTD 
volume R olfactory cortex 1.64 (.24- 12.15) AD>bvFTD 
volume R superior frontal gyrus, medial  4.54 (0.56 - 47.37) AD>bvFTD 
volume L gyrus rectus 0.45 (.05-3.74) AD<bvFTD 
volume R insula 2.60 (0.17-55.04) AD>bvFTD 
volume L middle occipital gyrus 2.09 (0.09-55.02) AD>bvFTD 
volume R middle occipital gyrus 0.05 (0.00 - 0.88) * AD<bvFTD 
volume L angular gyrus 0.07 (0.01-.0.49) * AD<bvFTD 
volume R precuneus 0.26 (0.02 - 2.03) AD<bvFTD 
volume R caudate nucleus 0.59 (0.12- 2.73) AD<bvFTD 
volume L thalamus 7.85 (1.35-64.24) * AD>bvFTD 
degree L superior occipital gyrus 0.18 (0.03- 0.86) * AD<bvFTD 
degree R middle  occipital gyrus 0.24 (0.04-1.14) AD<bvFTD 
degree L superior parietal gyrus 3.40 (0.89-17.06) AD>bvFTD 
degree L thalamus 2.72 (0.92-9.71) AD>bvFTD 
degree R heschl gyrus 1.19 (0.39 - 4.18) AD>bvFTD 
degree R middle temporal gyrus 3.88 (0.87-25.52) AD>bvFTD 
clustering L hippocampus 1.61 (0.39 - 7.73) AD>bvFTD 
clustering R hippocampus 0.63 (0.16-2.18) AD<bvFTD 
clustering L cuneus 0.42 (0.09 - 1.70) AD<bvFTD 
clustering L superior occipital gyrus 0.39 (0.07 - 1.81) AD<bvFTD 
clustering L angular gyrus 7.18 (2.13 - 37.53) * AD>bvFTD 
clustering R paracentral lobule 0.22 (0.06-0.58) * AD<bvFTD 
  m_age 1.74 (0.84 - 4.15) 
  
See figure 2 for anatomical regions. Key: AD, Alzheimer's disease; CI, confidence interval; bvFTD, behavioral variant 
Frontotemporal dementia; OR, odds ratio. All analyses were corrected for total grey matter volume, age, gender and 
scanner type. Significant at p(0.05). * is p < .05, ** is p < .01, *** is p < .001. 
  
                                                                                                                   Vijverberg et al. 28 
 
Table 4. Spearman’s rank correlations (rho) between the lasso logistic regression 
selected local properties of bvFTD versus AD and the categorized cognitive domains 
(Language, Attention and Executive)¶ and global cognition (MMSE) per disease. 
 
Network 
property 
Cortical region MMSE 
 
Language 
 
Attention 
 
Executive 
 
  
AD bvFTD AD bvFTD AD bvFTD AD bvFTD 
volume 
L superior frontal 
gyrus, orbital 
0.30** 0.33* 0.18 0.22 0.31** 0.22 0.31** 0.30* 
volume R olfactory cortex 0.37** 0.07 0.15 0.01 0.26* 0.01 0.31** 0.01 
volume 
R superior frontal 
gyrus, medial 
0.39** 0.15 0.15 0.06 0.24* 0.19 0.32** 0.23 
volume L gyrus rectus 0.17 0.21 0.18 0.05 0.36** 0.10 0.33** 0.12 
volume R insula 0.42** 0.10 0.12 0.01 0.33** 0.11 0.35** 0.14 
volume 
L middle occipital 
gyrus 
0.35** 0.14 0.04 (-)0.11 0.24* 0.19 0.28* 0.12 
volume 
R middle occipital 
gyrus 
0.28** 0.14 0.08 (-)0.10 0.26* 0.11 0.28* 0.10 
volume L angular gyrus 0.44** 0.19 0.10 0.07 0.20 0.27 0.24* 0.19 
volume R precuneus 0.42** 0.14 0.12 (-)0.08 0.15 0.11 0.29* 0.09 
volume R caudate nucleus 0.13 0.11 0.07 (-)0.04 0.20 0.07 0.26* 0.09 
volume L thalamus 0.23* 0.09 (-)0.04 (-)0.04 0.04 0.22 0.08 0.17 
degree 
L superior occipital 
gyrus 
0.11 0.10 0.15 0.06 0.14 0.28* 0.28* 0.17 
degree 
R middle  occipital 
gyrus 
0.26* 0.25 0.20 0.11 0.18 0.21 0.26* 0.17 
degree 
L superior parietal 
gyrus 
0.14 0.17 0.11 0.09 0.19 0.23 0.23 0.12 
degree L thalamus 0.11 0.14 0.11 (-)0.07 0.24* 0.23 0.28* 0.13 
degree R heschl gyrus (-)0.11 0.18 0.07 (-)0.12 0.01 0.12 (-)0.10 0.07 
degree 
R middle temporal 
gyrus 
0.19 0.17 0.16 0.09 0.27* 0.15 0.28* 0.12 
clustering L hippocampus (-)0.07 0.15 0.09 0.29* 0.03 0.13 (-)0.003 0.12 
clustering R hippocampus 0.01 0.31* 0.05 0.28 (-)0.10 0.25 (-)0.11 0.27* 
clustering L cuneus (-)0.01 0.07 0.03 0.17 (-)0.04 0.07 (-)0.05 0.02 
clustering 
L superior occipital 
gyrus 
0.19 0.12 (-)0.005 0.27 (-)0.05 0.15 (-)0.01 0.14 
clustering L angular gyrus 0.03 0.23 (-)0.001 0.13 (-)0.05 0.12 (-)0.05 0.09 
clustering R paracentral lobule 0.06 0.24 0.03 0.25 0.15 0.17 0.08 0.15 
 
Key: AD, Alzheimer's disease; bvFTD, behavioral variant Frontotemporal dementia; MMSE, Mini Mental-State 
Examination. ¶ We did not include the domains memory and visuospatial because no significant correlations were 
found. Significant at p(0.05). * is p < .05, ** is p < .01, *** is p < .001. 
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Legends of the figures 
Figure 1. Box plots showing differences in the distributions of global network 
properties values between SCD, AD and bvFTD. Box plots show the distributions of: a) degree: SCD 
versus AD/bvFTD: F = 17.50, p <0.001, b) connectivity density: SCD versus AD/bvFTD: F = 13.28, p<0.001 and AD 
versus bvFTD: F = 5.79, p =0.02, c) clustering: SCD versus AD/bvFTD: F = 13.28, p<0.001 and AD versus bvFTD: F 
= 3.79, p<0.05, d) path length: SCD versus AD/bvFTD: F = 17.21, p<0.001, e) betweenness centrality: SCD versus 
AD/bvFTD: F = 13.92, p<0.001 f) Lambda: SCD versus AD/bvFTD: 17.35, p<0.001, g) gamma: SCD versus 
AD/bvFTD: F = 20.14, p<0.001, h) small world: SCD versus AD/bvFTD: F = 17.50, p<0.001 and AD versus bvFTD: 
F= 0.45;  p=0.50. Middle line indicates the median value. All analyses were corrected for total grey matter volume, 
age, gender and scanner type. Key: bvFTD, behavioral variant Frontotemporal dementia; AD, Alzheimer's disease; 
SCD, subjective cognitive decline. 
 
Figure 2. Anatomical areas selected by lasso logistic regression of the local properties 
which were different between bvFTD versus AD (OR).  
Deeper blue colors are associated with higher odds for AD and the yellow-red spectrum is associated with higher 
odds for bvFTD. E.g., OR of 2 means that higher value in that area is associated with a 2-fold odds to be a FTD 
subject. A: volume (OR); L thalamus (7.85), L rectus (0.45), L frontal superior orbital (5.75), L middle occipital (2.09), 
L angular (0.07), R middle occipital (2.09), R olfactory (1.64), R medial frontal superior (4.54), R insula (2.60), R 
nucleus caudate (0.59), R precuneus (0.26). B: degree; L superior occipital (0.18), L superior parietal (3.40), L 
thalamus (2.72), R middle occipital (3.88), R heschl (1.19), R middle temporal pole (3.88). C: clustering; L superior 
occipital (0.39), L hippocampus (1.61), L angular (7.18), R paracentral (0.22), R hippocampus (0.63). See table 3 for 
OR 95% Confidence intervals and correlations with cognition. Key: bvFTD, behavioral variant Frontotemporal 
dementia; AD, Alzheimer's disease; OR, odds ratio. 
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Tables Supplementary 
 
Table S1. Scanner types and acquisition parameters 
 
Scanner  Protocol AD (n) bvFTD (n) SCD (n) 
1T Siemens magnetom 
Impact 
MPRAGE, coronal plane, TR 15 ms, 
TE 7 ms, TI 300 ms, FA 15°, voxel 
size 1×1×1.5 mm3; 
14 (23.7%) 20 (22.2%) 15 (20.3%) 
1.5T Siemens Sonata MPRAGE, coronal plane, TR 2700 ms, 
TE 3.97 ms, TI 950 ms, FA 8°, voxel 
size 1×1×1.5 mm3 
2 (3.4%) 2 (2.2%) 1 (1.4%) 
1.5t GE Signahdxt FSPGR, sagittal plane, TR 12.4 ms, 
TE 5.17 ms, TI 450 ms, FA 12°, voxel 
size 0.98×0.98×1.5 mm3 
5 (8,5%) 6 (6.7%) 5 (6.8%) 
3T GE Signahdxt FSPGR, sagittal plane, TR 708 ms, TE 
7 ms, FA 12°, voxel size 0.98×0.98×1 
mm3 
32 (54.2%) 56 (62.2%) 47 (63.5%) 
3T Philips Ingenuity 
PET/MR system 
TFE, sagittal plane, TR 7 ms, TE 3 
ms, FA 12°, voxel size 1×1×1 mm3 
6 (10.2%) 6 (6.7%) 6 (8.1%) 
 
Keys: bvFTD, behavioral variant Frontotemporal dementia; AD, Alzheimer's disease; SCD, Subjective cognitive 
decline; TR, repetition time; TE, echo time; TI, inverstion time; FA, flip angle. Chi-square test: p=0.979. 
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Table S2. Lasso logistic regression outcome of the local properties which were 
different between AD versus SCD (OR). 
 
Network 
property 
Cortical region OR (95% CI) 
volume L hippocampus 0.70(0.14-3.34)* 
volume L Amygdala 0.12(0.02-0.60) 
volume L angular gyrus 0.58(0.06-4.52)* 
volume L middle temporal gyrus 0.34 (0.02-3.38) 
clustering R inferior frontal gyrus, orbital 0.39(0.07-1.81) 
clustering R rolandic operculum 0.38(0.11-1.13) 
clustering R superior frontal gyrus, medial 0.72(0.17-2.88) 
clustering R calcarine fissure 1,.06(0.20-5.78) 
clustering L middle occipital gyrus 1.19(0.16-9.10) 
clustering L inferior occipital gyrus 0.80(0.19-3.09) 
clustering R caudate nucleus 1.09(0.28-4.29) 
clustering L middle temporal gyrus 0.76(0.08-6.63) 
clustering L inferior temporal gyrus 1.07(0.13-8.93) 
path length L rolandic operculum 0.42(0.15-1.01) 
path length L precuneus 0.47(0.15-1.31) 
path length L lenticular nucleus, putamen 3.11(1.14-10.4)* 
betweenness R inferior frontal gyrus, triangular 4.97(1.84-17.12)** 
betweenness L anterior cingulate 2.71(1.17-7.10)* 
 
Key: AD, Alzheimer disease; CI, confidence interval; OR, odds ratio; SCD, subjective cognitive decline. All analyses 
were corrected for total grey matter volume, age, gender and scanner type. Significant at p(0.05). * is p < .05, ** is p 
< .01, *** is p < .001. 
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Table S3. Lasso logistic regression outcome of the local properties which were 
different between bvFTD versus SCD (OR). 
 
Network 
property 
Cortical region OR (95% CI) 
volume L gyrus rectus 0.77 (0.38-1.53) 
volume L hippocampus 0.74 (0.32-1.69) 
volume R  caudate nucleus 0.72 (0.33-1.49) 
volume L middle temporal gyrus 0.81 (0.42-1.52) 
clustering R inferior frontal gyrus, orbital 0.53 (0.21-1.30) 
clustering R inferior occipital gyrus 0.37 (0.15-0.81) 
clustering L middle temporal gyrus 1.2 (0.43-3.43) 
path length L inferior frontal gyrus, opercular 0.60 (0.33-1.03)* 
path length R insula 0.65 (0.37-1.09) 
 
Key: CI, confidence interval; bvFTD, behavioral variant Frontotemporal dementia; OR, odds ratio; SCD, subjective 
cognitive decline. All analyses were corrected for total grey matter volume, age, gender and scanner type. Significant 
at p(0.05). * is p < .05, ** is p < .01, *** is p < .001. 
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